Earnings History Data for ENDRA Life Sciences Inc. (NDRA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-08-2024 | AH | NDRA | ENDRA Life Sciences Inc. | 0.56 | -0.08 | 0.00 | -0.43 | 0.0523 | 0.0 (-5.08%) |
0.05 | 0.0 (-2.00%) |
0.05 - 2.79 | 4,238,166 | 9,570,000 | 845,696 | |||
|
|
||||||||||||||||||
| 14-05-2024 | AH | NDRA | ENDRA Life Sciences Inc. | 3.30 | -0.26 | 0.00 | -0.93 | Endra Life Sciences GAAP EPS of -$0.26 beats by $0.01 [5/14/2024 4:17 PM] |
0.2905 | 0.0 (0.28%) |
0.30 | 0.01 (2.80%) |
0.22 - 2.79 | 103,423 | 100,000 | 758 | ||
| 28-03-2024 | AH | NDRA | ENDRA Life Sciences Inc. | 8.23 | -0.17 | 0.00 | -1.04 | Endra Life Sciences GAAP EPS of -$0.17 beats by $0.19 [3/28/2024 4:08 PM] |
0.58 | -0.24 (-29.29%) |
0.47 | -0.11 (-18.97%) |
0.57 - 2.91 | 948,741 | 190,000 | 185,050 | ||
| 14-11-2023 | AH | NDRA | ENDRA Life Sciences Inc. | 7.14 | -0.40 | 0.00 | 1.00 | Endra Life Sciences GAAP EPS of -$0.40 beats by $0.03 [11/14/2023 4:09 PM] |
0.97 | 0.03 (3.19%) |
0.94 | 0.0 (0.00%) |
0.87 - 5.95 | 23,612 | 30,000 | 183 | ||
| 14-08-2023 | AH | NDRA | ENDRA Life Sciences Inc. | 10.03 | -0.43 | 0.00 | -1.20 | Endra Life Sciences GAAP EPS of -$0.43 [8/14/2023 4:08 PM] |
1.11 | -0.14 (-11.55%) |
1.34 | 0.09 (6.77%) |
1.02 - 7.40 | 654,627 | 40,000 | 4,091 | ||
| 15-05-2023 | AH | 4:05 PM ET (May 15) |
NDRA | ENDRA Life Sciences Inc. | 4.37 | -0.93 | -1.02 | -1.40 | Endra Life Sciences GAAP EPS of -$0.93 beats by $0.11 [5/15/2023 4:10 PM] |
1.32 | 0.04 (3.12%) |
1.40 | 0.12 (9.38%) |
1.02 - 7.60 | 69,679 | 60,000 | 3,501 | |
| 14-03-2023 | AH | 4:05 PM ET (Mar 14) |
NDRA | ENDRA Life Sciences Inc. | 11.40 | -1.04 | -0.80 | -1.40 | Endra Life Sciences GAAP EPS of $1.04 beats by $1.94 [3/14/2023 4:12 PM] |
3.70 | -0.02 (-0.54%) |
3.70 | -0.05 (-1.33%) |
3.16 - 12.98 | 26,229 | 10,000 | 850 | |
| 14-11-2022 | AH | 4:05 PM ET (Nov 14) |
NDRA | ENDRA Life Sciences Inc. | 12.83 | -0.05 | -0.06 | -0.06 | Endra Life Sciences GAAP EPS of -$0.05 [11/14/2022 4:49 PM] |
0.2003 | -0.02 (-10.18%) |
0.20 | -0.02 (-8.88%) |
0.18 - 1.43 | 690,814 | 250,000 | 8,600 | |
| 15-08-2022 | AH | 4:05 PM ET (Aug 15) |
NDRA | ENDRA Life Sciences Inc. | 16.27 | -0.06 | -0.05 | -0.08 | Endra Life Sciences GAAP EPS of $0.06 beats by $0.12 [8/15/2022 4:19 PM] |
0.3363 | -0.02 (-6.84%) |
0.37 | 0.01 (2.49%) |
0.18 - 2.09 | 478,561 | 550,000 | 17,602 | |
| 12-05-2022 | AH | 4:05 PM ET (May 12) |
NDRA | ENDRA Life Sciences Inc. | 12.34 | -0.07 | -0.07 | -0.06 | Endra Life Sciences GAAP EPS of -$0.07 [5/12/2022 4:19 PM] |
0.1946 | 0.0 (-1.72%) |
0.21 | 0.01 (6.06%) |
0.18 - 2.44 | 1,618,682 | 1,610,000 | 55,549 | |
| 30-03-2022 | AH | 4:05 PM ET (Mar 30) |
NDRA | ENDRA Life Sciences Inc. | 15.88 | -0.07 | 0.00 | -0.10 | Endra Life Sciences GAAP EPS of -$0.28 [3/30/2022 4:12 PM] |
0.3804 | -0.02 (-4.88%) |
0.43 | 0.03 (7.53%) |
0.34 - 2.80 | 544,224 | 410,000 | 910 | |
|
||||||||||||||||||
| 15-11-2021 | AH | 7:05 PM ET (Nov 15) |
NDRA | ENDRA Life Sciences Inc. | 58.60 | -0.06 | -0.07 | -0.15 | Endra Life Sciences EPS beats by $0.02 [11/15/2021 5:31 PM] |
1.13 | -0.19 (-14.66%) |
1.15 | -0.18 (-13.53%) |
0.70 - 3.10 | 1,009,701 | 250,000 | 24,208 | |
|
||||||||||||||||||
| 12-08-2021 | AH | After the close (Aug 12) |
NDRA | ENDRA Life Sciences Inc. | 74.59 | -0.08 | -0.07 | -0.20 | Endra Life Sciences EPS misses by $0.01 [8/12/2021 4:36 PM] |
1.61 | -0.15 (-8.52%) |
1.73 | -0.03 (-1.70%) |
0.65 - 3.10 | 697,846 | 200,000 | 857 | |
| 17-05-2021 | AH | After the close (May 17) |
NDRA | ENDRA Life Sciences Inc. | 82.45 | -0.06 | -0.07 | -0.29 | Endra Life Sciences EPS beats by $0.01 [5/17/2021 4:12 PM] |
2.16 | 0.18 (9.09%) |
2.01 | 0.03 (1.52%) |
0.63 - 3.10 | 928,400 | 710,000 | 5,832 | |
| 25-03-2021 | AH | After the close (Mar 25) |
NDRA | ENDRA Life Sciences Inc. | 93.21 | -0.10 | -0.14 | -1.20 | Endra Life Sciences EPS beats by $0.08 [3/25/2021 4:15 PM] |
2.43 | 0.12 (5.19%) |
2.45 | 0.14 (6.06%) |
0.60 - 3.10 | 1,719,932 | 2,740,000 | 55,651 | |
| 16-11-2020 | AH | After the close (Nov 16) |
NDRA | ENDRA Life Sciences Inc. | 19.16 | -0.15 | -0.16 | -0.46 | Endra Life Sciences EPS beats by $0.02 [11/16/2020 4:21 PM] |
0.8338 | 0.02 (2.84%) |
0.77 | -0.04 (-5.03%) |
0.60 - 2.25 | 115,282 | 145,212 | 168 | |
|
|
||||||||||||||||||
| 14-08-2020 | AH | NDRA | ENDRA Life Sciences Inc. | 15.82 | -0.20 | 0.00 | -0.31 | 0.89 | -0.03 (-3.26%) |
0.9189 | 0.0 (-0.12%) |
0.60 - 2.25 | 158,059 | 546,653 | 4,047 | |||
|
|
||||||||||||||||||
| 14-05-2020 | AH | NDRA | ENDRA Life Sciences Inc. | 9.28 | -0.29 | 0.00 | -0.37 | Endra Life Sciences EPS beats by $0.05 [5/14/2020 4:09 PM] |
0.7099 | -0.01 (-0.75%) |
0.7070 | -0.01 (-1.16%) |
0.60 - 2.25 | 656,073 | 311,892 | 33,002 | ||
|
|
||||||||||||||||||